Global Dermal Drug Delivery System Market Research Report 2025

Publication ID:

PB505257407

Publication Date:

May 20, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global market for Dermal Drug Delivery System was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
DDS (drug delivery systems) are also called drug delivery systems.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Dermal Drug Delivery System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dermal Drug Delivery System.
The Dermal Drug Delivery System market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Dermal Drug Delivery System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dermal Drug Delivery System manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
3M
Antares Pharma
Pharmajet
Optinose
Valeritas
Crossject
Injex Pharma
ALZA Corporation
BD
MedImmune
Mystic Pharmaceuticals
Generex Biotechnology
Segment by Type
Oral
Injection
Transdermal
Segment by Application
Hospital
Clinic
Home Care
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Dermal Drug Delivery System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Dermal Drug Delivery System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Dermal Drug Delivery System Market Overview
1.1 Product Definition
1.2 Dermal Drug Delivery System by Type
1.2.1 Global Dermal Drug Delivery System Market Value Comparison by Type (2024 VS 2031)
1.2.2 Oral
1.2.3 Injection
1.2.4 Transdermal
1.3 Dermal Drug Delivery System by Application
1.3.1 Global Dermal Drug Delivery System Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Home Care
1.4 Global Dermal Drug Delivery System Market Size Estimates and Forecasts
1.4.1 Global Dermal Drug Delivery System Revenue 2020-2031
1.4.2 Global Dermal Drug Delivery System Sales 2020-2031
1.4.3 Global Dermal Drug Delivery System Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Dermal Drug Delivery System Market Competition by Manufacturers
2.1 Global Dermal Drug Delivery System Sales Market Share by Manufacturers (2020-2025)
2.2 Global Dermal Drug Delivery System Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Dermal Drug Delivery System Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Dermal Drug Delivery System, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Dermal Drug Delivery System, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Dermal Drug Delivery System, Product Type & Application
2.7 Global Key Manufacturers of Dermal Drug Delivery System, Date of Enter into This Industry
2.8 Global Dermal Drug Delivery System Market Competitive Situation and Trends
2.8.1 Global Dermal Drug Delivery System Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Dermal Drug Delivery System Players Market Share by Revenue
2.8.3 Global Dermal Drug Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Dermal Drug Delivery System Market Scenario by Region
3.1 Global Dermal Drug Delivery System Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Dermal Drug Delivery System Sales by Region: 2020-2031
3.2.1 Global Dermal Drug Delivery System Sales by Region: 2020-2025
3.2.2 Global Dermal Drug Delivery System Sales by Region: 2026-2031
3.3 Global Dermal Drug Delivery System Revenue by Region: 2020-2031
3.3.1 Global Dermal Drug Delivery System Revenue by Region: 2020-2025
3.3.2 Global Dermal Drug Delivery System Revenue by Region: 2026-2031
3.4 North America Dermal Drug Delivery System Market Facts & Figures by Country
3.4.1 North America Dermal Drug Delivery System Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Dermal Drug Delivery System Sales by Country (2020-2031)
3.4.3 North America Dermal Drug Delivery System Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Dermal Drug Delivery System Market Facts & Figures by Country
3.5.1 Europe Dermal Drug Delivery System Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Dermal Drug Delivery System Sales by Country (2020-2031)
3.5.3 Europe Dermal Drug Delivery System Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Dermal Drug Delivery System Market Facts & Figures by Region
3.6.1 Asia Pacific Dermal Drug Delivery System Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Dermal Drug Delivery System Sales by Region (2020-2031)
3.6.3 Asia Pacific Dermal Drug Delivery System Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Dermal Drug Delivery System Market Facts & Figures by Country
3.7.1 Latin America Dermal Drug Delivery System Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Dermal Drug Delivery System Sales by Country (2020-2031)
3.7.3 Latin America Dermal Drug Delivery System Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Dermal Drug Delivery System Market Facts & Figures by Country
3.8.1 Middle East and Africa Dermal Drug Delivery System Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Dermal Drug Delivery System Sales by Country (2020-2031)
3.8.3 Middle East and Africa Dermal Drug Delivery System Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Dermal Drug Delivery System Sales by Type (2020-2031)
4.1.1 Global Dermal Drug Delivery System Sales by Type (2020-2025)
4.1.2 Global Dermal Drug Delivery System Sales by Type (2026-2031)
4.1.3 Global Dermal Drug Delivery System Sales Market Share by Type (2020-2031)
4.2 Global Dermal Drug Delivery System Revenue by Type (2020-2031)
4.2.1 Global Dermal Drug Delivery System Revenue by Type (2020-2025)
4.2.2 Global Dermal Drug Delivery System Revenue by Type (2026-2031)
4.2.3 Global Dermal Drug Delivery System Revenue Market Share by Type (2020-2031)
4.3 Global Dermal Drug Delivery System Price by Type (2020-2031)
5 Segment by Application
5.1 Global Dermal Drug Delivery System Sales by Application (2020-2031)
5.1.1 Global Dermal Drug Delivery System Sales by Application (2020-2025)
5.1.2 Global Dermal Drug Delivery System Sales by Application (2026-2031)
5.1.3 Global Dermal Drug Delivery System Sales Market Share by Application (2020-2031)
5.2 Global Dermal Drug Delivery System Revenue by Application (2020-2031)
5.2.1 Global Dermal Drug Delivery System Revenue by Application (2020-2025)
5.2.2 Global Dermal Drug Delivery System Revenue by Application (2026-2031)
5.2.3 Global Dermal Drug Delivery System Revenue Market Share by Application (2020-2031)
5.3 Global Dermal Drug Delivery System Price by Application (2020-2031)
6 Key Companies Profiled
6.1 3M
6.1.1 3M Company Information
6.1.2 3M Description and Business Overview
6.1.3 3M Dermal Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.1.4 3M Dermal Drug Delivery System Product Portfolio
6.1.5 3M Recent Developments/Updates
6.2 Antares Pharma
6.2.1 Antares Pharma Company Information
6.2.2 Antares Pharma Description and Business Overview
6.2.3 Antares Pharma Dermal Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Antares Pharma Dermal Drug Delivery System Product Portfolio
6.2.5 Antares Pharma Recent Developments/Updates
6.3 Pharmajet
6.3.1 Pharmajet Company Information
6.3.2 Pharmajet Description and Business Overview
6.3.3 Pharmajet Dermal Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Pharmajet Dermal Drug Delivery System Product Portfolio
6.3.5 Pharmajet Recent Developments/Updates
6.4 Optinose
6.4.1 Optinose Company Information
6.4.2 Optinose Description and Business Overview
6.4.3 Optinose Dermal Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Optinose Dermal Drug Delivery System Product Portfolio
6.4.5 Optinose Recent Developments/Updates
6.5 Valeritas
6.5.1 Valeritas Company Information
6.5.2 Valeritas Description and Business Overview
6.5.3 Valeritas Dermal Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Valeritas Dermal Drug Delivery System Product Portfolio
6.5.5 Valeritas Recent Developments/Updates
6.6 Crossject
6.6.1 Crossject Company Information
6.6.2 Crossject Description and Business Overview
6.6.3 Crossject Dermal Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Crossject Dermal Drug Delivery System Product Portfolio
6.6.5 Crossject Recent Developments/Updates
6.7 Injex Pharma
6.7.1 Injex Pharma Company Information
6.7.2 Injex Pharma Description and Business Overview
6.7.3 Injex Pharma Dermal Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Injex Pharma Dermal Drug Delivery System Product Portfolio
6.7.5 Injex Pharma Recent Developments/Updates
6.8 ALZA Corporation
6.8.1 ALZA Corporation Company Information
6.8.2 ALZA Corporation Description and Business Overview
6.8.3 ALZA Corporation Dermal Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.8.4 ALZA Corporation Dermal Drug Delivery System Product Portfolio
6.8.5 ALZA Corporation Recent Developments/Updates
6.9 BD
6.9.1 BD Company Information
6.9.2 BD Description and Business Overview
6.9.3 BD Dermal Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.9.4 BD Dermal Drug Delivery System Product Portfolio
6.9.5 BD Recent Developments/Updates
6.10 MedImmune
6.10.1 MedImmune Company Information
6.10.2 MedImmune Description and Business Overview
6.10.3 MedImmune Dermal Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.10.4 MedImmune Dermal Drug Delivery System Product Portfolio
6.10.5 MedImmune Recent Developments/Updates
6.11 Mystic Pharmaceuticals
6.11.1 Mystic Pharmaceuticals Company Information
6.11.2 Mystic Pharmaceuticals Description and Business Overview
6.11.3 Mystic Pharmaceuticals Dermal Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Mystic Pharmaceuticals Dermal Drug Delivery System Product Portfolio
6.11.5 Mystic Pharmaceuticals Recent Developments/Updates
6.12 Generex Biotechnology
6.12.1 Generex Biotechnology Company Information
6.12.2 Generex Biotechnology Description and Business Overview
6.12.3 Generex Biotechnology Dermal Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Generex Biotechnology Dermal Drug Delivery System Product Portfolio
6.12.5 Generex Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dermal Drug Delivery System Industry Chain Analysis
7.2 Dermal Drug Delivery System Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dermal Drug Delivery System Production Mode & Process Analysis
7.4 Dermal Drug Delivery System Sales and Marketing
7.4.1 Dermal Drug Delivery System Sales Channels
7.4.2 Dermal Drug Delivery System Distributors
7.5 Dermal Drug Delivery System Customer Analysis
8 Dermal Drug Delivery System Market Dynamics
8.1 Dermal Drug Delivery System Industry Trends
8.2 Dermal Drug Delivery System Market Drivers
8.3 Dermal Drug Delivery System Market Challenges
8.4 Dermal Drug Delivery System Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

3M
Antares Pharma
Pharmajet
Optinose
Valeritas
Crossject
Injex Pharma
ALZA Corporation
BD
MedImmune
Mystic Pharmaceuticals
Generex Biotechnology

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂